ES2186166T3 - Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal. - Google Patents

Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.

Info

Publication number
ES2186166T3
ES2186166T3 ES98924850T ES98924850T ES2186166T3 ES 2186166 T3 ES2186166 T3 ES 2186166T3 ES 98924850 T ES98924850 T ES 98924850T ES 98924850 T ES98924850 T ES 98924850T ES 2186166 T3 ES2186166 T3 ES 2186166T3
Authority
ES
Spain
Prior art keywords
peritoneal dialysis
natural peptide
anp
additive
dialysis solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98924850T
Other languages
English (en)
Inventor
Chi J Chen
Ty R Shockley
Miles G Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2186166T3 publication Critical patent/ES2186166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA SOLUCION PARA DIALISIS PERITONEAL QUE CONTIENE UN PEPTIDO NATRIURETICO ATRIAL (PNA), UN DERIVADO DEL PNA, UN ANALOGO DEL PNA, UNA SUBSTANCIA QUE FIJA EL PNA A RECEPTORES DEL ACLARAMIENTO, O UNA SUBSTANCIA QUE PROMUEVE LA SINTESIS DEL PNA, Y QUE DA COMO RESULTADO UN AUMENTO DE LA ULTRAFILTRACION NETA Y UN AUMENTO DEL ACLARAMIENTO DEL SODIO EXPERIMENTADO EN PACIENTES DE DIALISIS PERITONEAL.
ES98924850T 1997-05-23 1998-05-21 Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal. Expired - Lifetime ES2186166T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/862,480 US5965533A (en) 1997-05-23 1997-05-23 Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions

Publications (1)

Publication Number Publication Date
ES2186166T3 true ES2186166T3 (es) 2003-05-01

Family

ID=25338600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98924850T Expired - Lifetime ES2186166T3 (es) 1997-05-23 1998-05-21 Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.

Country Status (12)

Country Link
US (1) US5965533A (es)
EP (1) EP0914147B1 (es)
JP (1) JP2000516836A (es)
KR (1) KR20000029447A (es)
CN (1) CN1226832A (es)
AU (1) AU733210B2 (es)
BR (1) BR9804921A (es)
CA (1) CA2261681A1 (es)
DE (1) DE69808717T2 (es)
ES (1) ES2186166T3 (es)
ID (1) ID21765A (es)
WO (1) WO1998052599A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303812T1 (de) * 1998-07-07 2005-09-15 Terumo Corp Lösung für die peritonealdialyse
JP2002524723A (ja) * 1998-09-04 2002-08-06 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション パラクリンの尿細管レニン−アンジオテンシン系に基づく薬物スクリーニングおよび診断
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CA2647146A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
KR101434612B1 (ko) * 2006-03-30 2014-08-26 팔라틴 테크놀로지스 인코포레이티드 사이클릭 나트륨 이뇨 펩타이드 구조물
JP5207316B2 (ja) * 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
AU2010274293B9 (en) 2009-07-23 2013-08-29 Igisu Co., Ltd. Skin external-preparation composition
AU2010287421B2 (en) 2009-08-27 2013-06-13 Kyoko Endo Therapeutic agent for rhinitis
ES2647680T3 (es) 2011-01-21 2017-12-26 Igisu Co., Ltd. Fármaco terapéutico para la alopecia
WO2014197806A2 (en) * 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258368A (en) * 1984-04-19 1993-11-02 Scios Nova, Inc. Atrial natriuretic/vasodilator peptide compounds
US5212286A (en) 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US4618600A (en) 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1987006938A1 (en) 1986-05-09 1987-11-19 Biotechnology Research Associates, J.V. Atrial natriuretic peptide receptor protein and its encoding dna
WO1989000428A1 (en) * 1987-07-17 1989-01-26 Brigham And Women's Hospital Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
EP0429537A4 (en) 1988-08-18 1991-08-21 California Biotechnology, Inc. Atrial natriuretic peptide clearance inhibitors
US5106834A (en) 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
JP2000516836A (ja) 2000-12-19
EP0914147B1 (en) 2002-10-16
DE69808717D1 (de) 2002-11-21
US5965533A (en) 1999-10-12
BR9804921A (pt) 1999-09-08
EP0914147A1 (en) 1999-05-12
CN1226832A (zh) 1999-08-25
AU733210B2 (en) 2001-05-10
CA2261681A1 (en) 1998-11-26
WO1998052599A1 (en) 1998-11-26
AU7692698A (en) 1998-12-11
DE69808717T2 (de) 2003-06-12
ID21765A (id) 1999-07-22
KR20000029447A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
BR0112430A (pt) Composição tópica para cuidado da pele, para cuidado pessoal, e processo para regularizarem a condição da pele e para reduzirem o aparecimento de linhas finas e rugas na pele
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
BR9709823A (pt) Amidas de piridil alqueno-e priridil alquino-ácido como citostáticos e imuno-supressores
BR0207726A (pt) Sais farmacêuticos
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2177323T3 (es) Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
ES2185595T3 (es) Peptidos antivirales modificados y sus composiciones para la prevencion y/o el tratamiento de infecciones viricas.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
SV1996000026A (es) Benzociclopentano oxazolidinonas que contienen heteroatomos
BR0312549A (pt) Derivados de indolin-fenilsulfonamida
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ES2183351T3 (es) Composicones que comprenden conjugados de proteina ob humana activa estable con una cadena fc de inmunoglobulinas y metodos.
ES2186166T3 (es) Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
BR0311347A (pt) Alcanóis bis-aromáticos
NO973548L (no) Behandling av diabetisk neuropati
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
AR023699A1 (es) Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
DK0952853T3 (da) Konjugat omfattende et aktivt middel, et polypeptid og en polyether
SE7803646L (sv) Salva for huddesinfektion och sett att framstella densamma
ES2160834T3 (es) Derivado de fenil pirimidina opticamente activo como agente analgesico.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.